A study by Gassman et al. found that small molecules known for suppressing Kinesin in Drosophila (SBL-154, SBL-185, and SBL-190) can rescue motor axon abnormalities from transgenic Smn-deficient and MO-injected zebrafish SMA models. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.